🇺🇸 FDA
Pipeline program

Doxorubicin 2 mg/ml Solution for Injection., Fibromun

PH-L19TNFDOX2-03/16

Phase 3 small_molecule active

Quick answer

Doxorubicin 2 mg/ml Solution for Injection., Fibromun for Unresectable or metastatic soft tissue sarcoma is a Phase 3 program (small_molecule) at Philogen S.p.A. with 1 ClinicalTrials.gov record(s).

Program details

Company
Philogen S.p.A.
Indication
Unresectable or metastatic soft tissue sarcoma
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials